NCT06443723Completed
Metabolic Dysfunction Associated Fatty Liver Disease in Long-Term Cholecystectomy Patients
Metabolic Dysfunction Associated Fatty Liver Disease in Long-Term Cholecystectomy: A Cross-sectional Case-control Study
Source: ClinicalTrials.gov · Last updated 5 Jun 2024
Brief summary (registry, in English)
The aim of this study was to examine the association between metabolic associated fatty liver disease (MAFLD) in participants who had undergone cholecystectomy and those who had not undergone cholecystectomy. MAFLD is defined as hepatic steatosis(with ultrasonography) entity in addition to the presence of overweight or obesity, diabetes mellitus, or evidence of metabolic dysfunction. In this way, the long-term effects of cholecystectomy surgeries, which are commonly performed in the society and thought to be harmless, will be evaluated.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 149 (actual)
- First submitted
- 19 May 2024
- Start date
- 1 Nov 2023
- Primary completion date
- 30 Apr 2024
- Lead sponsor
- Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
- Diseases
- Obesity, Fatty liver disease (MASLD/MASH)
- NCT number
- NCT06443723
What you commit to
- Study type: Interventional
- Participants enrolled: 149
- From 1 Nov 2023 to the primary completion date, 30 Apr 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- in a chemotherapy program
- use of drugs that cause steatosis in the liver
Other illness
- those with chronic liver disease
- malignancy or history of malignancy
- with active infection
- any organ failure
Other
- pregnancy
Who the study is looking for
- who were found to have undergone cholecystectomy at least five years ago,
- who could feed orally and perform activities of daily living
- participants who had not undergone cholecystectomy with similar characteristics were included in the study
Age in the registry: 18 years to 80 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital Coordinator of this site? Confirm its status | Ankara | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.